Ind-Swift Labs to sell API and CRAMS business to Synthimed for Rs 1,650cr
In a groundbreaking move that has left the pharmaceutical sector buzzing, the Board of Directors of Ind-Swift Laboratories Limited ("Ind-Swift") announced the blockbuster sale of ... Read More
Ind-Swift Laboratories to divest Dubai-based subsidiary to Soft Air General Trading
Ind-Swift Laboratories Limited has agreed to sell its fully-owned Dubai-based subsidiary — Ind-Swift Middle East FZ-LLC (ISME) to UAE-based Soft Air General Trading, for a ... Read More